BioTalentum Joins the SynMech Consortium

BioTalentum Joins the SynMech Consortium

We are pleased to announce that as of October 1, 2024, BioTalentum Ltd. has officially joined the SynMech Consortium.

Established in 2005, BioTalentum is a research and technology development (RTD) intensive SME that specializes in stem cell research and services, with a strong focus on EU project management, advisory, and training.

BioTalentum’s scientific focus is on medical and animal biotechnologies, concentrating on stem cell research (human, mouse, rabbit iPSCs, embryonic stem cells, 2D and 3D patient specific iPSC-derived neuronal, cardiac, beta-cells and other cell types) for disease modelling, toxicology and regenerative medicine. Their expertise in human 2D and 3D iPSC-derived neuronal cell types will significantly enhance our efforts to model diseases relevant to the SynMech project.

We are thrilled to welcome BioTalentum aboard and look forward to the innovative contributions they will bring to our collaborative initiatives. Together, we are committed to introduce radically new neuro-stimulation technologies and bring them from bench to bedside.

Leave a Reply

Your email address will not be published. Required fields are marked *